César Millán-Pacheco

Prof. César Millán-Pacheco

Pharmacy Faculty, UAEM
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Critical Reviews in Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
KBKrisztina Z. Bencze
Krisztina Z. Bencze
KKKalyan C. Kondapalli
Kalyan C. Kondapalli
JCJeremy D. Cook
Jeremy D. Cook
SMStephen McMahon
Stephen McMahon
CMCésar Millán-Pacheco
César Millán-Pacheco
TSTimothy Stemmler
Timothy Stemmler
Frataxin, a highly conserved protein found in prokaryotes and eukaryotes, is required for efficient regulation of cellular iron homeostasis. Humans with a frataxin deficiency have the cardio- and neurodegenerative disorder Friedreich's ataxia, commonly resulting from a GAA trinucleotide repeat expansion in the frataxin gene. While frataxin's specific function remains a point of controversy, the general consensus is that the protein assists in controlling cellular iron homeostasis by directly binding iron. This review focuses on the structural and biochemical aspects of iron binding by the frataxin orthologs and outlines molecular attributes that may help explain the protein's role in different cellular pathways.

28 March 2007 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
KBKrisztina Z. Bencze
Krisztina Z. Bencze
TYTaejin Yoon
Taejin Yoon
CMCésar Millán-Pacheco
César Millán-Pacheco
PBPatrick B. Bradley
Patrick B. Bradley
NPNina Pastor
Nina Pastor
TSTimothy Stemmler
Timothy Stemmler
The coordinated iron structure and ferrochelatase binding surface of human frataxin have been characterized to provide insight into the protein's ability to serve as the iron chaperone during heme biosynthesis.

11 January 2019 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
ACAldo F. Clemente‑Soto
Aldo F. Clemente‑Soto
ESEnrique Salas‑Vidal
Enrique Salas‑Vidal
CMCésar Millán-Pacheco
César Millán-Pacheco
OPOscar Peralta‑Zaragoza
Oscar Peralta‑Zaragoza
JSJessica Nayelli Sánchez‑Carranza
Jessica Nayelli Sánchez‑Carranza
LGLETICIA GONZALEZ-MAYA
LETICIA GONZALEZ-MAYA
Cervical cancer is the second most common cancer in women worldwide. Human papillomavirus (HPV) infection appears to be a necessary factor in the development of almost all cases (>95%) of cervical cancer. HPV E6 induces a change of control of p53 stabilization from Hdm2 to E6/E6AP in HPV‑infected cells. It is well known that the LxxLL motif of cellular ubiquitin ligase E6AP binds to the pocket of E6 and causes a conformational change to enable E6 to bind p53 competently. In the ternary complex E6/E6AP/p53, p53 is polyubiquitinated by E6AP and subsequently degraded by a proteasome. Therefore, these cells are deficient in the processes regulated by p53, including apoptosis, damaged DNA repair, and the cell cycle. In the present study, it was demonstrated that quercetin induced G2 phase cell cycle arrest and apoptosis in both HeLa and SiHa cells, accompanied by an increase of p53 and its nuclear signal. It was also observed that quercetin increased the level of the p21 transcript and the pro‑apoptotic Bax protein, which are two p53‑downstream effectors. However, quercetin did not alter the expression of the HPV E6 protein in cervical cancer cells; therefore, the increase in p53 occurred in an E6 expression‑independent manner. Furthermore, molecular docking demonstrated that quercetin binds stably in the central pocket of E6, the binding site of E6AP. These data suggest that quercetin increases the nuclear localization of p53 by interrupting E6/E6AP complex formation in cervical cancer cells.

26 July 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
JEJames Elste
James Elste
ASAkash Saini
Akash Saini
RMRafael Mejia-Alvarez
Rafael Mejia-Alvarez
AMArmando Mejía
Armando Mejía
CMCésar Millán-Pacheco
César Millán-Pacheco
VTVaibhav Tiwari
Vaibhav Tiwari
A highly critical event in a virus’s life cycle is successfully entering a given host. This process begins when a viral glycoprotein interacts with a target cell receptor, which provides the molecular basis for target virus–host cell interactions for novel drug discovery. Over the years, extensive research has been carried out in the field of virus–host cell interaction, generating a massive number of genetic and molecular data sources. These datasets are an asset for predicting virus–host interactions at the molecular level using machine learning (ML), a subset of artificial intelligence (AI). In this direction, ML tools are now being applied to recognize patterns in these massive datasets to predict critical interactions between virus and host cells at the protein–protein and protein–sugar levels, as well as to perform transcriptional and translational analysis. On the other end, deep learning (DL) algorithms—a subfield of ML—can extract high-level features from very large datasets to recognize the hidden patterns within genomic sequences and images to develop models for rapid drug discovery predictions that address pathogenic viruses displaying heightened affinity for receptor docking and enhanced cell entry. ML and DL are pivotal forces, driving innovation with their ability to perform analysis of enormous datasets in a highly efficient, cost-effective, accurate, and high-throughput manner. This review focuses on the complexity of virus–host cell interactions at the molecular level in light of the current advances of ML and AI in viral pathogenesis to improve new treatments and prevention strategies.

1 December 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FHFernando Hernández
Fernando Hernández
ASArturo Sánchez
Arturo Sánchez
PRPriscila Rendón-Vallejo
Priscila Rendón-Vallejo
CMCésar Millán-Pacheco
César Millán-Pacheco
YAYolanda Alcaraz
Yolanda Alcaraz
SESamuel Estrada-Soto
Samuel Estrada-Soto

1 June 2020 in Life Sciences
Verified
Journal Article
Closed access
JVJ.D. Villeda-González
J.D. Villeda-González
JGJ.L. Gómez-Olivares
J.L. Gómez-Olivares
LBL.A. Baiza-Gutman
L.A. Baiza-Gutman
LML. Manuel-Apolinar
L. Manuel-Apolinar
LDL. Damasio-Santana
L. Damasio-Santana
MDM. Díaz-Flores
M. Díaz-Flores